| Business Summary | | SYNAVANT
Inc.
serves
the
pharmaceutical
industry
by
developing
and
selling
pharmaceutical
relationship
management
solutions
that
support
sales
and
marketing
decision-making
and
program
implementation.
SYNAVANT
offers
sales
and
marketing
effectiveness
solutions
that
can
be
integrated
with
all
client-critical
databases
to
provide
customer
and
business
insights.
SYNAVANT
configures
solutions
for
clients'
sales
and
marketing
teams,
which
include
supporting
desktop,
laptop,
handheld
PC,
and
paper
systems,
linked
to
client
companies'
databases
as
required.
Sales
to
the
pharmaceutical
industry
accounted
for
substantially
all
of
SYNAVANT's
revenue
in
2000.
Through
the
Company's
telecommunications
programs,
SYNAVANT
provides
a
direct
and
responsive
means
of
maintaining
interactive
communications
with
a
target
audience.
This
capability
provides
both
in-bound
and
out-bound
capabilities
to
healthcare
professionals,
sales
representatives,
and
consumers. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | SNVT
serves
the
pharmaceutical
industry
by
developing
and
selling
pharmaceutical
relationship
management
solutions
that
support
sales
and
marketing
decision
making.
For
the
six
months
ended
6/30/01,
total
revenues
fell
3%
to
$90.8
million.
Net
loss
increased
51%
to
$15.9
million.
Revenues
reflect
the
divestiture
of
EMRON
and
lower
Interactive
marketing.
Net
loss
also
reflects
higher
S/G/A
expenses
due
to
costs
associated
with
being
a
public
company. | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| Wayne Yetter, 55 Chairman,
CEO | $1.1M | Craig Kussman, 42 Exec.
VP, CFO, Chief Admin. Officer | 370K | Jim Cain Sr. VP of Global Marketingand Customer Devel. | -- | Robert Holmes Sr.
VP, Americas | -- | Ken Tyson Sr. VP, International | -- | Dollar
amounts are as of 30-Nov-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|